Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-11-09 Young Donald R VP of Quality Assurance Grant or award · Stock Option (right to buy) +30,000 30,000
2016-11-09 Fisher Douglas Director Grant or award · Stock Option (right to buy) +46,500 46,500
2016-11-09 Brister Mark VP of Research and Development Grant or award · Stock Option (right to buy) +90,000 90,000
2016-11-09 VandenBerg Amy VP of Reg. and Clin. Affairs Grant or award · Stock Option (right to buy) +30,000 30,000
2016-11-09 Stevenson Sharon Director Grant or award · Stock Option (right to buy) +46,500 46,500
2016-11-09 Rasdal Andrew P President & CEO Grant or award · Stock Option (right to buy) +300,000 300,000
2016-11-09 Plovanic William J. Chief Financial Officer Grant or award · Stock Option (right to buy) +55,000 55,000
2016-11-09 Norwood Matthew VP of Sales Grant or award · Stock Option (right to buy) +35,000 35,000
2016-11-09 Metzner Lisa VP of Marketing Grant or award · Stock Option (right to buy) +40,000 40,000
2016-11-09 Johnson Steven Ernest VP of Operations Grant or award · Stock Option (right to buy) +40,000 40,000
2016-11-09 Hussainy Nooshin VP of Finance Grant or award · Stock Option (right to buy) +40,000 40,000
2016-11-09 HOWE LESLEY H Director Grant or award · Stock Option (right to buy) +20,638 20,638
2016-11-09 DITTAMORE RAYMOND V Director Grant or award · Stock Option (right to buy) +20,638 20,638
2016-11-09 Kamdar Kim P. Director Grant or award · Stock Option (Right to Buy) +46,500 46,500
2016-10-12 DP VII ASSOCIATES LP 10% owner Conversion +49,570 49,570
2016-10-12 DP VII ASSOCIATES LP 10% owner Conversion · Series A Preferred Stock −11,083 0
2016-10-12 DP VII ASSOCIATES LP 10% owner Conversion · Series B Preferred Stock −20,583 0
2016-10-12 DP VII ASSOCIATES LP 10% owner Conversion · Series C Preferred Stock −14,271 0
2016-10-12 DOMAIN PARTERS VII L P 10% owner Conversion +3,985,970 3,985,970
2016-10-12 DOMAIN PARTERS VII L P 10% owner Conversion · Series A Preferred Stock −649,835 0

Page 15 of 17 · 322 trades